LANTERN PHARMA INC (LTRN) Stock Ownership and Short Interest
USA - NASDAQ:LTRN - US51654W1018 - Common Stock
4.4 USD
-0.01 (-0.23%)
| Shares Outstanding | 10.80M |
| Float | 9.28M |
| Float Short Interest Percentage | 4.04% |
| Owners (insider) | 0.42% |
| Owners (institutional) | 20.97% |
| Owners (insider) change | 0% |
| Owners (institutional) change | 0% |
Insider Transactions
Top Institutional Holders
Insider Owners
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Jun 13, 2025 | Bios Equity Partners II, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Capital Management, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Advisors GP, LLC | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Kreis Leslie W. | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Cavu Management, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Cavu Advisors, LLC | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BP Directors, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Fletcher Aaron G.L. | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund I, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund I QP, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund II, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund II QP, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund II NT, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Bios Equity Partners, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| May 27, 2025 | Fletcher Aaron G.L. | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund I, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund I QP, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund II, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund II QP, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund II NT, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Bios Equity Partners, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Bios Equity Partners II, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Capital Management, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Advisors GP, LLC | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Kreis Leslie W. | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Cavu Management, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Cavu Advisors, LLC | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BP Directors, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |